Kim Petras New Year’s Eve At The Abbey is now official. If you were considering making The Abbey a part of your New Year’s Eve plans, add this to the list of reasons to say yes.
MISTR is presenting the night and says the Grammy Award-winning icon will also be its 2026 ambassador. They describe the collab as a blend of music and sexual health. MISTR said the NYE event is part of a bigger campaign kicking off in early 2026. It will include public appearances in “key markets”, fan events, cultural moments and music video shoots, all tied to her latest album release. Just guessing here, but I would assume cultural moments might include Pride. MISTR is a gay-owned telemedicine platform that provides free online access to PrEP, DoxyPEP, STI and Hepatitis C testing and treatment, plus long-term HIV care.
Tristan Schukraft, founder and CEO of MISTR and owner of The Abbey, said Petras’ public persona fits the organization’s message. He says “Kim is fearless and unapologetically sex-positive. Her confidence, playfulness, and stigma-free approach to life align perfectly with our mission at MISTR to make sexual healthcare accessible and free.” Adding that her new album represents how Kim is entering “a freer, more powerful chapter, and we’re excited to celebrate this new era together.”
Petras also said she wants sexual health to be discussed openly, not treated like something people only talk about in whispers. “MISTR is changing the way we talk about sexual health by making it open, accessible, and real. We’re celebrating together on New Year’s Eve at The Abbey and continuing that momentum into 2026. Sexual health should be normalized, not whispered about, and MISTR is leading that shift” she said.
New Year’s Eve at the Abbey is always a magnet, but with Kim Petras headlining the night you can expect the place to be pretty lit.
MISTR used the announcement to highlight its free services, including PrEP, DoxyPEP and STI testing, offered online to insured and uninsured patients. The company describes PrEP as HIV prevention medication, and DoxyPEP as a prevention option intended to reduce the risk of certain bacterial STIs. MISTR also pointed to research it says was published through Emory University’s Rollins School of Public Health in JAMA, describing the company’s telehealth model as a growing part of how people access PrEP.
More 2026 events tied to the partnership are expected to be announced later. MISTR’s services are free for insured and uninsured patients, with no doctor’s office visits or paperwork, and medications delivered at no cost. More info is at mistr.com and sistr.com.
